Evidence map›Paper›PMID 24497581›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2014

Glutamate prevents intestinal atrophy via luminal nutrient sensing in a mouse model of total parenteral nutrition.

Weidong Xiao, Yongjia Feng, Jens J Holst, Bolette Hartmann, Hua Yang, Daniel H Teitelbaum

Abstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 41 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Effect of dietaryAnimal nutrition (Zhongguo xu mu shou yi xue hui) · 2020
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Intestine, immunity, and parenteral nutrition in an era of preferred enteral feeding.Current opinion in clinical nutrition and metabolic care · 2015
    Review
  18. Modulation of intestinal L-glutamate transport by luminal leptin.Journal of physiology and biochemistry · 2015
    Article
  19. Duodenal luminal nutrient sensing.Current opinion in pharmacology · 2014
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Weidong Xiao1Section of Pediatric Surgery, University of Michigan, Mott Children's Hospital F3970, Ann Arbor, MI 48109-5245, USA. dttlbm@umich.edu.
Yongjia Feng
Jens J Holst
Bolette Hartmann
Hua Yang
Daniel H Teitelbaum
University of Michigan–Ann Arbor · USUniversity of Copenhagen · DKXinqiao Hospital · CN

Funding

TPN INDUCED CHANGES IN INTRAEPITHELIAL LYMPHOCYTESR01AI044076 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI TEITELBAUM, DANIEL H · 2004 to 2014
$3.2M
NIAID NIH HHS 2R01AI-44076-14NIAID NIH HHS R01 AI044076
6 · The paper itself

Abstract

Small intestine luminal nutrient sensing may be crucial for modulating physiological functions. However, its mechanism of action is incompletely understood. We used a model of enteral nutrient deprivation, or total parenteral nutrition (TPN), resulting in intestinal mucosal atrophy and decreased epithelial barrier function (EBF). We examined how a single amino acid, glutamate (GLM), modulates intestinal epithelial cell (IEC) growth and EBF. Controls were chow-fed mice, T1 receptor-3 (T1R3)-knockout (KO) mice, and treatment with the metabotropic glutamate receptor (mGluR)-5 antagonist MTEP. TPN significantly changed the amount of T1Rs, GLM receptors, and transporters, and GLM prevented these changes. GLM significantly prevented TPN-associated intestinal atrophy (2.5-fold increase in IEC proliferation) and was dependent on up-regulation of the protein kinase pAkt, but independent of T1R3 and mGluR5 signaling. GLM led to a loss of EBF with TPN (60% increase in FITC-dextran permeability, 40% decline in transepithelial resistance); via T1R3, it protected EBF, whereas mGluR5 was associated with EBF loss. GLM led to a decline in circulating glucagon-like peptide 2 (GLP-2) during TPN. The decline was regulated by T1R3 and mGluR5, suggesting a novel negative regulator pathway for IEC proliferation not previously described. Loss of luminal nutrients with TPN administration may widely affect intestinal taste sensing. GLM has previously unrecognized actions on IEC growth and EBF. Restoring luminal sensing via GLM could be a strategy for patients on TPN.

Indexed as

Animal Nutrition SciencesAnimalsAtrophyCell ProliferationDisease Models, AnimalDown-RegulationEpithelial CellsEpitheliumFoodGlucagon-Like Peptide 2Glutamic AcidIntestinal MucosaJejunumMaleMiceMice, Inbred C57BL3-((2-methyl-1,3-thiazol-4-yl)ethynyl)piperidineGlucagon-Like Peptide 2Glutamic AcidGrm5 protein, mousePiperidinesReceptor, Metabotropic Glutamate 5Receptors, G-Protein-Coupledtaste receptors, type 1Thiazolesepithelial barrier functionmetabotropic glutamate receptorproliferationtaste receptor

Identifiers

PMID24497581
PMCPMC3986837
OpenAlexW2121440732

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.